Gastrointestinal bleeding

The European Commission has approved Tecentriq ( Atezolizumab ) in combination with Avastin ( Bevacizumab ) for the treatment of...


The European Commission ( EC ) has granted conditional marketing authorization to Ayvakyt ( Avapritinib ) as a monotherapy for...


The FDA ( U.S. Food and Drug Administration ) has approved Tecentriq ( Atezolizumab ) in combination with Avastin (...


The FDA ( U.S. Food and Drug Administration ) has approved Ofev ( Nintedanib ) capsules to slow the rate...


The results from an independent retrospective comparative study, published in the American Journal of Medicine, have shown that Dabigatran was...


The U.S. Food and Drug Administration ( FDA ) has approved Cyramza ( Ramucirumab injection, 10 mg/mL solution ), as...


A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that using long-term...


The U.S. Food and Drug Administration ( FDA ) has approved once-daily Yosprala, the only prescription fixed-dose combination of Aspirin,...


In the Apixaban for Prevention of Acute Ischemic Events ( APPRAISE-2 ) trial, the use of Apixaban ( Eliquis ),...


The FDA ( Food and Drug Administration ) has approved Vonvendi ( von Willebrand factor [ recombinant ] ). Vonvendi...


New oral anticoagulants for stroke prevention in atrial fibrillation were developed to be given in fixed doses without the need...


The recent availability of Dabigatran ( Pradaxa ), a novel oral anticoagulant, provided a new treatment option for stroke prevention...


The Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMA ) issued...


The FDA ( Food and Drug Administration ) has granted approval to Lenvima ( Lenvatinib ) to treat patients with...


Among patients without cardiovascular disease ( CVD ) and low 10-year CVD risk, the risks of gastrointestinal bleeding and hemorrhagic...


A FDA ( Food and Drug Administration ) study of more than 134,000 Medicare patients found that Pradaxa ( Dabigatran...


The comparative safety of Dabigatran ( Pradaxa ) versus Warfarin ( Coumadin ) for treatment of non-valvular atrial fibrillation in...


It remains unclear whether Dabigatran etexilate mesylate ( Pradaxa ) is associated with higher risk of bleeding than Warfarin sodium...


Eli Lilly has announced that the FDA ( Food and Drug Administration ) has approved Cyramza ( Ramucirumab ) as...


Four new oral anticoagulants compare favourably with Warfarin ( Coumadin ) for stroke prevention in patients with atrial fibrillation; however,...